2009
DOI: 10.1007/s00404-009-1147-4
|View full text |Cite
|
Sign up to set email alerts
|

Does residual amniotic fluid after preterm premature rupture of membranes have an effect on perinatal outcomes? 12 years experience of a tertiary care center

Abstract: A residual AFI < 50 mm after preterm PROM between 24 and 34 weeks of gestation, which is mostly seen in grand multiparous women in Eastern Turkey, may be a valuable prognostic variable for anticipating adverse maternal and neonatal outcomes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
16
5

Year Published

2012
2012
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(27 citation statements)
references
References 15 publications
6
16
5
Order By: Relevance
“…The concept that oligohydramnios is associated with adverse outcomes is not new, however, results from previous studies have been conflicting and contradictory [1][2][3][4][5][6][7][8][9][10][11][12][13]. Our data indicated that oligohydramnios was associated with an earlier gestational age at PPROM.…”
Section: Discussionmentioning
confidence: 59%
See 2 more Smart Citations
“…The concept that oligohydramnios is associated with adverse outcomes is not new, however, results from previous studies have been conflicting and contradictory [1][2][3][4][5][6][7][8][9][10][11][12][13]. Our data indicated that oligohydramnios was associated with an earlier gestational age at PPROM.…”
Section: Discussionmentioning
confidence: 59%
“…Low residual amniotic fluid after PPROM has been associated with complications such as short latency period, chorioamnionitis, neonatal sepsis, respiratory distress syndrome, low Apgar scores, cesarean deliveries, and neonatal death [1][2][3][4][5][6][7][8][9][10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Also, in Park et al [13] study, patients did not receive prophylactic antibiotics and some received tocolysis, which may have interfered with the association described in his study. Borna et al [9] and Kurdoglu et al [8] did not observe a difference in the gestational age of delivery between the groups.…”
Section: Discussionmentioning
confidence: 84%
“…The more recent literature has focused prevalently on two ROM biomarker tests: the AmniSure ® ROM Test (AmniSure ® lnternational LLC, Boston, MA, USA), based on the detection of placental α -microglobulin 1 ( PAMG-1), and the Actim ® Prom Test (Oy Medix Biochemica Ab, Kauniainen, Finland), based on the detection of insulinlike growth factor binding protein (IGFBP-1) [12,25,27,39] . The test based on PAMG-1 is the more recent of the two, with the first study on it being published in 2005, vs. 1996 for the test based on IGFBP-1 [8,41] .…”
Section: Introductionmentioning
confidence: 99%